Chronic cutaneous leishmaniasis in an immunocompetent patient:: response to miltefosine

被引：1
|
作者：
Ruiz-Villaverde, R.
Sanchez-Cano, D.
Villaverde-Gutierrez, C.
机构：
[1] Complejo Hosp Jaen, Dermatol Unit, Jaen, Spain
[2] Hosp Clin Granada, Granada, Spain
来源：
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY | 2007年 / 21卷 / 05期
关键词：
D O I：
10.1111/j.1468-3083.2006.01990.x
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：695 / 696
页数：2
相关论文
共 50 条
  • [31] Miltefosine-related paracentral ulcerative keratolysis in a patient with active cutaneous leishmaniasis from Nepal
    Khatri, Anadi
    Sah, Ranjit
    Timalsena, Satish
    Kharel, Muna
    [J]. TROPICAL DOCTOR, 2020, 50 (04) : 392 - 394
  • [32] Cutaneous leishmaniasis with multiple ulcerated lesions in an immunocompetent patient caused by Leishmania major
    Poortinga, Sietske
    Altengarten, Julia
    Wenzel, Joerg
    Reiter-Owona, Ingrid
    Maier, Judith
    Bieber, Thomas
    Balakirski, Galina
    [J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2020, 18 (06): : 625 - 627
  • [33] In Vitro and In Vivo Miltefosine Susceptibility of a Leishmania amazonensis Isolate from a Patient with Diffuse Cutaneous Leishmaniasis
    Coelho, Adriano C.
    Trinconi, Cristiana T.
    Costa, Carlos H. N.
    Uliana, Silvia R. B.
    [J]. PLOS NEGLECTED TROPICAL DISEASES, 2014, 8 (07):
  • [34] Case Report: Erysipeloid Cutaneous Leishmaniasis Treated with Oral Miltefosine
    Parajuli, Niraj
    Adhikary, Sabeena
    Karki, Anupama
    Tiwari, Sumida
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2021, 104 (02): : 643 - 645
  • [35] Efficacy of topical Miltefosine formulations in an experimental model of cutaneous leishmaniasis
    Peralta, Ma. Florencia
    Usseglio, Nadina A.
    Bracamonte, Ma. Estefania
    Guzman, Ma. Laura
    Olivera, Ma. Eugenia
    Marco, J. Diego
    Barroso, Paola A.
    Carrer, Dolores C.
    [J]. DRUG DELIVERY AND TRANSLATIONAL RESEARCH, 2022, 12 (01) : 180 - 196
  • [36] Dynamics of Parasite Clearance in Cutaneous Leishmaniasis Patients Treated with Miltefosine
    Dorlo, Thomas P. C.
    van Thiel, Pieter P. A. M.
    Schoone, Gerard J.
    Stienstra, Ymkje
    van Vugt, Michele
    Beijnen, Jos H.
    de Vries, Peter J.
    [J]. PLOS NEGLECTED TROPICAL DISEASES, 2011, 5 (12)
  • [37] Noninferiority of Miltefosine Versus Meglumine Antimoniate for Cutaneous Leishmaniasis in Children
    Consuelo Rubiano, Luisa
    Consuelo Miranda, Maria
    Muvdi Arenas, Sandra
    Mery Montero, Luz
    Rodriguez-Barraquer, Isabel
    Garcerant, Daniel
    Prager, Martin
    Osorio, Lyda
    Ximena Rojas, Maria
    Perez, Mauricio
    Santiago Nicholls, Ruben
    Gore Saravia, Nancy
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2012, 205 (04): : 684 - 692
  • [38] Efficacy of topical Miltefosine formulations in an experimental model of cutaneous leishmaniasis
    Ma. Florencia Peralta
    Nadina A. Usseglio
    Ma. Estefanía Bracamonte
    Ma. Laura Guzmán
    Ma. Eugenia Olivera
    J. Diego Marco
    Paola A. Barroso
    Dolores C. Carrer
    [J]. Drug Delivery and Translational Research, 2022, 12 : 180 - 196
  • [39] Pharmacokinetics of miltefosine in patients treated for old world cutaneous leishmaniasis
    Dorlo, T. P. C.
    Hillebrand, M. J. X.
    Rosing, H.
    Eggelte, T. A.
    Van Thiel, P. P. A. M.
    Van Vugt, M.
    Faber, W. R.
    De Vries, P. J.
    Beijnen, J. H.
    [J]. TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2007, 12 : 93 - 93
  • [40] Successful treatment with miltefosine of disseminated cutaneous leishmaniasis in a severely immunocompromised patient infected with HIV-1
    Schraner, C
    Hasse, B
    Hasse, U
    Baumann, D
    Faeh, A
    Burg, G
    Grimm, F
    Mathis, A
    Weber, R
    Günthard, HF
    [J]. CLINICAL INFECTIOUS DISEASES, 2005, 40 (12) : E120 - E124
12345